Becker's ASC Review

July_August_2018_ASC

Issue link: https://beckershealthcare.uberflip.com/i/1013711

Contents of this Issue

Navigation

Page 39 of 47

40 FDA permits marketing of Hemospray to treat GI bleeding: 5 things to know By Shayna Korol T he FDA permitted marketing of Hemospray, a new endoscopic device for gastrointestinal bleed- ing treatment. Here are five things to know: 1. The FDA permitted Wilson-Cook Medical to market the device. 2. The Hemospray device is an aerosolized spray that delivers a mineral blend to the bleeding site. It is used during endoscopic procedures and is designed to cover large areas, such as ulcers or tumors. 3. The device is intended to treat most types of upper and lower GI bleeding. It is not intended for use in pa- tients with variceal bleeding. 4. The device is contraindicated in patients who have a gastrointestinal fistula or are at a high risk of gastrointes- tinal perforation. 5. The FDA reviewed the Hemospray device through the de novo premarket review pathway for novel low-to- moderate risk devices. n Gastro Health to acquire South Florida Gastroenterology Associates — Adds 15 providers, 7 offices By Eric Oliver M iami-based Gastro Health will acquire Boynton Beach-based South Florida Gas- troenterology Associates. Here's what you should know: 1. The acquisition expands Gastro Health's presence in Boca Raton, Delray Beach and Wellington, and it establishes a new footprint in Boynton Beach, Jupiter and Lake Worth. All practices are in Florida. 2. South Florida Gastroenterology is a 15-physician practice with seven offices and two affiliated ASCs. All will bear the Gastro Health moniker once the acquisition closes. 3. As a result of the acquisition, Gastro Health will have 46 offices across Florida with 110 physicians on staff. 4. Gastro Health CEO Joseph Garcia said in a release, "Patient needs continue to drive our growth and we are thrilled to partner with SFGA. SFGA is a quality group of provid- ers that truly cares about the patient experience. Together, we will continue to fortify our position in Florida." n Call: 844-SUTURES info@eSutures.com • eSutures.com Over 1 million surgical items in stock and ready to ship same day! result in a loss. Aer conducting this type of analysis, an ASC can bring in some higher-paying proce- dures to offset lower-paying ones. Non-compliant billing. If an ASC does not stay on top of changes, a coder could unknowingly be submitting non-compliant bills. In some instances, the coder could be "upcoding," meaning that the ASC is asking for and getting paid for more than what they are sup- posed to receive. If a payer audits these claims, the ASC might have to refund the money — oen in greater amounts than what they received initially. On the flip side, if the coder is under-coding, the ASC will miss out on revenue that they should have been receiving. Want to avoid these consequences? Make sure that your ASC continu- ally keeps tracks of contractual and coding changes and puts strategies in place to deal with them. n

Articles in this issue

Links on this page

view archives of Becker's ASC Review - July_August_2018_ASC